This is a Validated Antibody Database (VAD) review about mouse Gosr1, based on 7 published articles (read how Labome selects the articles), using Gosr1 antibody in all methods. It is aimed to help Labome visitors find the most suited Gosr1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Gosr1 synonym: AI414660; AI426320; BB145494; GOS-28; GOSRI; GS28
Santa Cruz Biotechnology
mouse monoclonal (F-11) |
| Santa Cruz Biotechnology Gosr1 antibody (Santa Cruz Biotechnology, sc-271551) was used in western blot on human samples at 1:500 (fig s1k). Nat Commun (2020) ncbi |
Abcam
domestic rabbit monoclonal (EP1768Y) |
| Abcam Gosr1 antibody (Abcam, ab53288) was used in western blot on African green monkey samples (fig 1b). J Biol Chem (2018) ncbi |
BD Biosciences
mouse monoclonal (1/GS28) |
| BD Biosciences Gosr1 antibody (BD Biosciences, 611185) was used in immunohistochemistry on fruit fly |
mouse monoclonal (1/GS28) |
| BD Biosciences Gosr1 antibody (BD Transduction Laboratories, 611184) was used in western blot on human samples (fig 1d). Autophagy (2019) ncbi |
mouse monoclonal (1/GS28) |
| BD Biosciences Gosr1 antibody (BD Biosciences, 611185) was used in immunocytochemistry on mouse samples (fig 1f). J Neurosci (2018) ncbi |
mouse monoclonal (1/GS28) |
| BD Biosciences Gosr1 antibody (BD Biosciences, 611184) was used in western blot on human samples (fig 6d). elife (2016) ncbi |
mouse monoclonal (1/GS28) |
| In order to study the regulatory role of Arf1 in the Golgi and in hypersecretion in neuroendocrine cancer cells, BD Biosciences Gosr1 antibody (BD Biosciences, 611184) was used in immunocytochemistry on human samples . J Cell Mol Med (2015) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments